Maximize development velocity and eliminate operations toil with this indie-favorite serverless, event-driven, no-ops stack.
The data layer underneath an agentic system must handle variable schemas, vector embeddings, real-time retrieval, and ...
Real-time data improves visibility and speeds up issue detection, reducing downtime and delays. Live metrics enable faster, more effective production decisions and help optimize performance on the ...
Website traffic from AI agents and bots has eclipsed its human-generated counterpart for the first time, according to Cloudflare, an earlier-than-expected milestone that speaks to AI’s rapid advance ...
The service could make it simpler and cheaper to develop grounded applications by reducing the need for custom web-search infrastructure, analysts say. For the past two years, enterprises have focused ...
Opening moments of games can often feel long and slow, and may even be boring as the game must teach you how to play it first thing. They’re a necessary evil, but there's a new high bar, as the new ...
OpenAI said Thursday that its API will now include a number of new voice intelligence features designed to help developers create apps that can talk, transcribe, and translate conversations with users ...
OpenAI explains in more detail what’s new with the GPT-5-class GPT-Realtime-2 voice model with reasoning: GPT‑Realtime‑2 is built for live voice interactions where the model keeps the conversation ...
May 7 (Reuters) - OpenAI introduced three audio models for its developer platform on Thursday, aiming to make voice-based software agents more ‌conversational and capable of completing tasks in real ...
WHITE OAK, MD – The US Food and Drug Administration (FDA) has announced plans for a future pilot program intended to facilitate the real-time review of clinical trials by regulators, as well as the ...
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.
Why does it take a new drug 10 years, on average, to come to market? Part of the reason lies in the dead time in the process. Historically, trials have required tedious tabulations and repeated ...